Market Place
Sourcing Support
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Wanted: OPPORTUNITIES IN THE DRUG SHORTAGE LIST - APIs urgently needed in US and Canada
Wouldnt it be wonderful if the products that are manufactured, have such great demand that, they fly
